Surgical Science Sweden AB (publ) (STO:SUS)
Sweden · Delayed Price · Currency is SEK 48.80
-0.82 (-1.65%)
Sep 24, 2026, 5:29 PM CET
STO:SUS Market Cap
STO:SUS has a market cap or net worth of 2.49 billion as of September 24, 2026. Its market cap has decreased by -45.78% in one year.
Market Cap
2.49B
Enterprise Value
1.83B
Revenue
1.02B
Ranking
n/a
PE Ratio
26.81
Stock Price
48.80
ChartMarket Cap Chart
Since June 19, 2017, STO:SUS's market cap has increased from 279.67M to 2.49B, an increase of 790.35%. That is a compound annual growth rate of 26.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 2.49B | 50.15% |
| Dec 30, 2025 | 1.66B | -79.15% |
| Dec 30, 2024 | 7.95B | -14.58% |
| Dec 29, 2023 | 9.31B | 11.30% |
| Dec 30, 2022 | 8.37B | -41.49% |
| Dec 30, 2021 | 14.30B | 343.39% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 19, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 155.98B |
| Getinge AB | 66.95B |
| Sectra AB | 53.68B |
| Medicover AB | 39.36B |
| CellaVision AB | 4.01B |
| Egetis Therapeutics AB | 3.62B |
| Hansa Biopharma AB | 3.46B |
| Humana AB | 3.25B |